Understand the source comparison
Real Peptides AHK-Cu vs Competitors Quality: Feature Comparison
Before reviewing the comparison table below, understand that these aren't marketing claims—every specification listed for Real Peptides references third-party verification data available on request. Competitor data reflects publicly available CoAs and independ
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Before reviewing the comparison table below, understand that these aren't marketing claims—every specification listed for Real Peptides references third-party verification data available on request. Competitor data reflects publicly available CoAs and independent testing results published in peer-reviewed analysis.
- Advertised Purity
- 99%+
- 98%
- 98.5%
- CoA Claim
- Claims are uniform—verification methods are not
- Third-Party Verified Purity
- 99.2% (HPLC)
- Not disclosed
- 95.8% (independent study)
- ISO 17025 lab HPLC
- Real Peptides provides verifiable data; competitors rely on in-house claims
- Batch-to-Batch Variability
- <0.5%
- 2.3–4.1%
- 3.7–5.2%
- Comparative CoA analysis
- Consistent purity requires small-batch synthesis
- Copper Ion Binding Ratio
- 98–99%
- Not tested
- 87–91%
- Mass spec coordination analysis
- Lower binding ratios reduce biological activity by 20–30%
- TFA Residual Content
- 0.03%
- 0.9–1.4%
- 0.6–1.1%
- Ion chromatography
- TFA >0.1% interferes with cell culture assays
- Deletion Sequence Content
- <0.3%
- 4–6%
- 3.8–5.5%
- HPLC peak analysis
- Deletion sequences compete for receptors without activating them
- Shelf Stability (−20°C)
- 18+ months
- 8–10 months
- 6–9 months
- Accelerated degradation testing
- Proper copper chelation and low oxidation extend usable lifespan
- Price per 50mg
- Higher
- Lower
- Mid-range
- Market pricing
- Cost-per-active-milligram favors higher purity when biological activity is factored